| Mahesh Shrestha, | |
|
123 Summer St, Worcester, MA 01608-1216 | |
| (508) 363-6208 | |
| Not Available |
| Full Name | Mahesh Shrestha |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 14 Years |
| Location | 123 Summer St, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215345269 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 259802 (Massachusetts) | Secondary |
| 207R00000X | Internal Medicine | 259802 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Hospital- Emory Healthcare | Columbus, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeastern Hospitalist Services Pc | 3476855420 | 276 |
News Archive
What happens if humans perceive either familiar or unfamiliar objects? The answer to these questions may lie in the direction of information flow transmitted between specialized brain areas that together establish a dynamic cortical network.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg.
All persons taking strontium supplements are warned that significant risks have been identified. Strontium drugs are not approved for treatment of osteoporosis in the United States. Now, the Risk Assessment Committee of the European Medicines Agency recommended that strontium should no longer be used to treat osteoporosis in Europe. The drugs Protelos/Osseor were specifically named as brand names for strontium ranelate.
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that dosing has begun in its Phase IIa clinical study of its investigational compound IW-3718 in patients suffering from gastroesophageal reflux disease (GERD) who have not responded adequately to treatment with a proton pump inhibitor (PPI). Data are expected in the first half of 2015.
› Verified 5 days ago
| Entity Name | Southeastern Hospitalist Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003280108 PECOS PAC ID: 3476855420 Enrollment ID: O20160107001140 |
News Archive
What happens if humans perceive either familiar or unfamiliar objects? The answer to these questions may lie in the direction of information flow transmitted between specialized brain areas that together establish a dynamic cortical network.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg.
All persons taking strontium supplements are warned that significant risks have been identified. Strontium drugs are not approved for treatment of osteoporosis in the United States. Now, the Risk Assessment Committee of the European Medicines Agency recommended that strontium should no longer be used to treat osteoporosis in Europe. The drugs Protelos/Osseor were specifically named as brand names for strontium ranelate.
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that dosing has begun in its Phase IIa clinical study of its investigational compound IW-3718 in patients suffering from gastroesophageal reflux disease (GERD) who have not responded adequately to treatment with a proton pump inhibitor (PPI). Data are expected in the first half of 2015.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mahesh Shrestha, 673 Franklin St, Apt 201 A, Worcester, MA 01604-1847 Ph: (857) 234-5474 | Mahesh Shrestha, 123 Summer St, Worcester, MA 01608-1216 Ph: (508) 363-6208 |
News Archive
What happens if humans perceive either familiar or unfamiliar objects? The answer to these questions may lie in the direction of information flow transmitted between specialized brain areas that together establish a dynamic cortical network.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg.
All persons taking strontium supplements are warned that significant risks have been identified. Strontium drugs are not approved for treatment of osteoporosis in the United States. Now, the Risk Assessment Committee of the European Medicines Agency recommended that strontium should no longer be used to treat osteoporosis in Europe. The drugs Protelos/Osseor were specifically named as brand names for strontium ranelate.
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that dosing has begun in its Phase IIa clinical study of its investigational compound IW-3718 in patients suffering from gastroesophageal reflux disease (GERD) who have not responded adequately to treatment with a proton pump inhibitor (PPI). Data are expected in the first half of 2015.
› Verified 5 days ago
Dr. Adepeju Gbadebo Champion, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-2731 Fax: 774-442-4672 | |
Madaiah Lokeshwari, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 Summer St, Worcester, MA 01608 Phone: 508-363-6849 | |
Sowmya Korapati, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-3550 Fax: 774-442-6715 | |
Irma Hashmi, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 | |
Dr. Madhav Sharma, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 123 Summer St, Worcester, MA 01608 Phone: 508-363-5438 | |
Daniel M Steigman, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 123 Summer Street, Suite 390, Worcester, MA 01608 Phone: 508-368-3120 Fax: 508-368-3121 | |
Dr. Julia D Andrieni, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave N, Department Of General Medicine, Worcester, MA 01655 Phone: 508-334-2731 |